biosimilars
Basics and Benefits of Biosimilars: A Rheumatologist’s Take
The use of biosimilars can improve patient access and reduce healthcare costs, but understanding some basic ...
FEBRUARY 21, 2025
Biosimilars: Expanding Options For Inflammatory Disease Treatment
Biologics are mainstays of treatment for many chronic inflammatory conditions. Unfortunately, these drugs often ...
NOVEMBER 26, 2024
Pros and Cons to Updating Biosimilar Switching Guidance
The FDA proposed removing the requirement that biosimilar drug manufacturers submit clinical switching studies to ...
NOVEMBER 15, 2024
FDA Updates Biosimilars Action Plan
The FDA updated its Biosimilars Action Plan (first released in 2018) to reinforce its strategy to further expand ...
JULY 19, 2024
FDA Approves Biosimilar to RA Drug
The FDA approved Simlandi injection, the first interchangeable high-concentration, citrate-free biosimilar to ...
MARCH 11, 2024
First Biosimilar to Humira Launches
Adalimumab-atto, an anti-tumor necrosis factor (TNF)-alpha monoclonal antibody, was the first biosimilar to Humira ...
FEBRUARY 13, 2023
FDA Approves New Formula for Rheumatologic Biosimilar
The FDA approved a citrate-free, high-concentration (100 mg/mL) formulation of Hadlima, a biosimilar referencing ...
AUGUST 22, 2022
Biosimilar Approved to Treat Moderate to Severe RA
The FDA has approved rituximab-arrx for adults with moderate to severe active RA.
JUNE 8, 2022
Leveraging the EHR Among Tools for Boosting Biosimilars
Despite the promise of huge savings with biosimilars—an estimated $140 billion in discounted spending over ...
OCTOBER 28, 2021
Pharmacists Show Their Skill In Easing Biosimilar Switches
Managing biosimilar adoption and utilization has become almost a specialty in itself for many health-system ...
JULY 29, 2021
Come Together to Increase Biosimilar Uptake
The use of biosimilars could be higher if stakeholders, from manufacturers to payors and pharmacists, united to ...
MAY 27, 2021
Overcoming Biosimilar Hesitancy
Biosimilars have the potential to significantly reduce costs for medical centers, but the adoption rate is still ...
JANUARY 8, 2021
